Kaposi's Sarcoma clinical trials at UCSF
2 research studies open to eligible people
Ixazomib for Kaposi Sarcoma
open to eligible people ages 18 years and up
This phase II trial studies how well ixazomib works in treating patients with Kaposi sarcoma. Ixazomib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
San Francisco, California and other locations
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
open to eligible people ages 18 years and up
This study collects blood and tissue samples for research of human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS)-related cancers. Collecting blood and tissue samples and studying biomarkers in the laboratory may help doctors to learn how are biologic or genetic factors related to HIV and cancers that occur commonly in people living with HIV.
San Francisco, California and other locations
Our lead scientists for Kaposi's Sarcoma research studies include Chia-Ching Wang, MD.
Last updated: